A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Clinical trial NCT03970382 · SUSPENDED
Trial details
- NCT number
- NCT03970382
- Sponsor
- PACT Pharma, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2022-08-12
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.